Chairman, CEO of Johnson & Johnson (JNJ, Financial) Alex Gorsky sold 264,465 shares of JNJ on 11/16/2018 at an average price of $145.96 a share. The total sale was $38.6 million.
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of products in the health care field within its Consumer, Pharmaceutical and Medical Devices segments. Johnson & Johnson has a market cap of $390.86 billion; its shares were traded at around $145.99 with a P/E ratio of 286.25 and P/S ratio of 4.90. The dividend yield of Johnson & Johnson stocks is 2.39%. Johnson & Johnson had annual average EBITDA growth of 3.90% over the past ten years. GuruFocus rated Johnson & Johnson the business predictability rank of 2-star.
CEO Recent Trades:
- Chairman, CEO Alex Gorsky sold 264,465 shares of JNJ stock on 11/16/2018 at the average price of $145.96. The price of the stock has increased by 0.02% since.
Directors and Officers Recent Trades:
- Controller, CAO Ronald A Kapusta sold 8,441 shares of JNJ stock on 11/08/2018 at the average price of $145.15. The price of the stock has increased by 0.58% since.
- Vice Chair, Exec Committee Joaquin Duato sold 40,000 shares of JNJ stock on 11/07/2018 at the average price of $144.36. The price of the stock has increased by 1.13% since.
For the complete insider trading history of JNJ, click here
.
